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Formation of a ribonucleoprotein particle (mRNP) competent for export requires the coupling of transcrip-
tion with mRNA processing and RNA export. A key link between these processes is provided by the THO
complex. To progress in our understanding of this coupling, we have performed a search for suppressors of the
transcription defect caused by the hpr1 mutation. This has permitted us to identify mutations in the genes
for the RNA polymerase II mediator component Med10, the Sch9 protein kinase, and the Ypr045c protein. We
report a role in transcription elongation for Ypr045c (Thp3) and the Csn12 component of the COP9 signalo-
some. Thp3 and Csn12 form a complex that is recruited to transcribed genes. Their mutations suppress the
gene expression defects of THO complex mutants involved in mRNP biogenesis and export and show defects
in mRNA accumulation. Transcription elongation impairment of thp3 mutants is shown by in vivo transcript
run-on analysis performed in G-less systems. Thp3-Csn12 establishes a novel link between transcription and
mRNA processing that opens new perspectives on our understanding of gene expression and reveals novel
functions for a component of the COP9 signalosome. Thp3-Csn12 also copurifies with ribosomal proteins,
which opens the possibility that it has other functions in addition to transcription.
Formation of a mature ribonucleoprotein particle (mRNP)
competent for export requires the correct coupling of tran-
scription with mRNA processing steps such as 5-end capping,
splicing, 3-end cleavage, and polyadenylation, as well as with
RNA export (1, 4, 9, 42). A connection between mRNP for-
mation and transcription is provided by the conserved THO
complex. In Saccharomyces cerevisiae, THO is composed of
stoichiometric amounts of Tho2, Hpr1, Mft1, and Thp2 (7). It
is recruited to active chromatin, functions during transcription
elongation and RNA export, and physically associates with the
RNA-dependent ATPase Sub2/UAP56 in a larger protein
complex termed TREX (61). Different results reveal a func-
tional relationship between THO and RNA export. These in-
clude the findings that mutations in RNA export factors such
as Sub2, Yra1, the Mex67-Mtr2 heterodimer, or Nab2 hnRNP
confer gene expression defects similar to those of THO mu-
tants and that THO mutations confer synthetic lethality with
RNA export mutations (35, 61). A hallmark of THO mutants
is their strong genome instability phenotype that is linked to
transcription elongation impairment and to the cotranscrip-
tional formation of R loops (DNA-RNA hybrids) (2, 31).
The THSC complex, also termed TREX-2 (composed of
Thp1, Sac3, Sus1, and Cdc31), is also involved in mRNP bio-
genesis and export, and the mutant forms of its components
also confer gene expression and mRNA export defects and
increased genome instability similar to those of THO mutants
(19, 22, 24, 56, 68). Despite their similar phenotypes, in con-
trast to THO, which is found all over the nucleus, THSC is
located primarily at the nuclear periphery in association with
nucleoporins (19, 40). Notably, it has recently been shown that
THSC physically interacts with Sem1 (15, 66), a factor that, in
addition, interacts with other complexes such as the 19S pro-
teasome (21) and the COP9 signalosome (CSN) (15). THSC,
the proteasome, and the CSN all have among their compo-
nents a subunit with a Sac3 domain and another subunit with
a PAM domain (8, 15, 66).
The CSN was first identified in Arabidopsis thaliana as an
eight-subunit complex involved in the suppression of light-
dependent development (63). It is conserved from fission yeast
to humans and is thought to be a regulator of signaling and
developmental processes (20, 48, 65). The CSN is a multisub-
unit protease that regulates the activity of cullin-RING ligase
families of ubiquitin E3 complexes via its deneddlyase activity.
The conserved NEDD8 protein (Rub1 in S. cerevisiae) can be
conjugated to substrate proteins in a process known as neddy-
lation, a posttranslational protein modification closely related
to ubiquitination. Neddylation is essential in most model or-
ganisms but not in S. cerevisiae, and it is reversed by NEDD8
isopeptidases such as yeast CSN5, a component of the CSN
(see reference 54). In addition to its deneddylation function, it
has also been shown that CSN influences the DNA damage
response, cell cycle control, and gene expression, although the
mechanism underlying these actions is unknown (6, 43). A
CSN-like complex has been described in S. cerevisiae that it is
composed of six subunits, Csn5, Csn9, Csn10, Csn11, Csn12,
and Csi1 (46).
Despite the increasing data supporting the coupling between
transcription and RNA export and its impact on genome in-
stability, the function of the factors involved in this process is
* Corresponding author. Mailing address: Centro Andaluz de Bi-
ología Molecular y Medicina Regenerativa (CABIMER), Av. Ame´rico
Vespucio s/n, 41092 Seville, Spain. Phone: 34 954468372. Fax: 34
954461664. E-mail: aguilo@us.es.
† Supplemental material for this article may be found at http://mcb
.asm.org/.
 Published ahead of print on 13 December 2010.
674
 o
n
 O
ctober 5, 2015 by USE/BCTA.G
EN UNIVERSITARIA
http://m
cb.asm
.org/
D
ow
nloaded from
 
far from clear. To further understand this coupling, as medi-
ated by the THO complex, we have performed a search for
suppressors of the transcription defect of hpr1 that has per-
mitted us to identify mutations in the gene of the RNA poly-
merase II (RNAPII) mediator component Med10, the Sch9
protein kinase, and the Ypr045c protein of unknown function.
They suppress the transcription and RNA export defects, as
well as the hyperrecombination phenotype, of THO mutants.
A thorough analysis reveals that Ypr045c is recruited to tran-
scribed chromatin and has a functional role in transcription
elongation in vivo, even though an additional role in initiation
cannot be excluded. We show that this novel protein, named
Thp3, forms a physical and functional unit with the Csn12
component of the CSN and copurifies with ribosomal proteins.
Our work establishes a new link between RNAPII transcrip-
tion and a protein complex related to the CSN.
MATERIALS AND METHODS
Strains and plasmids. The yeast strains used in this study are listed in Table 1.
Plasmid pCYC-LacZ was constructed by amplifying the lacZ gene from plasmid
pCM184-LAUR with oligonucleotides LacZUp (5AAGTACTCGAGACCAT
GATTACGGAT3) and LacZ-Down (5TCAGATCCGCGGTCGCTATGACG
3) using Pfu polymerase. A 2-kb fragment was cloned into pG-Leu-CYCds
digested with XhoI after filling with Klenow fragment (C. Tous et al., unpub-
lished data). Plasmids pG-Leu-CYCds (60), pCM184-LAUR and pCM184-
LYNS (35), and pCM189-LEU2 (25) were previously described. For the am-
plification of the FLAG constructs, we used the pU6H10F plasmid (12).
Tn3 insertion mutagenesis. Strain U678-1C was transformed with a yeast
genomic library mutagenized by the insertion of an mTn3-lacZ/LEU2 transposon
(5). Sites of Tn3 insertions were identified by the “vectorette” PCR rescue
protocol (http://ygac.med.yale.edu/mtn/insertion_libraries.stm).
Chromatin immunoprecipitation (ChIP) analysis. For ChIP experiments,
strains were grown either in rich medium (for PMA1) or in synthetic complete
(SC) medium containing 2% glycerol and 2% lactate to an optical density at 600
nm (OD660) of 0.5 (for GAL1). For GAL1 ChIPs, the culture was split in two and
one half was supplemented with 2% glucose (repressed transcription) and the
other was supplemented with 2% galactose (activated transcription). Samples
were then taken after 4 h of induction, and ChIP assays were performed as
described previously (30). Anti-Rpb1-CTD monoclonal antibody 8WG16
(Berkeley Antibody Company) and protein A-Sepharose were used for RNAPII
immunoprecipitation, and anti-FLAG M2 monoclonal antibody from Sigma was
used for Hpr1-FLAG immunoprecipitation. Tandem affinity purification (TAP)-
tagged versions of Thp3 and Csn12 were used. The GFX purification system
(Amersham) was used for the last DNA purification step. We used the PCR of
the intergenic region at positions 9716 to 9863 of chromosome V as a negative
control. Real-time quantitative PCR and calculation of the relative abundance of
each DNA fragment were performed as described previously (32). For each
experiment, the DNA ratios in the different regions were calculated from the
amount of DNA in these regions relative to that in the intergenic region. Me-
dians and standard deviations (SD) of three independent experiments are shown.
TABLE 1. Yeast strains used in this study
Strain Genotype Reference orsource
AYW3-3C MAT ade2-1 can1-100 his3 ura3 leu2-k::ADE2-URA3::leu2-k hpr1HIS3 58
W303-1A MATa ade2-1 can1-100 his3-11 trp1-1 ura3-1 leu2-3,112 R. Rothstein
WMK-1A MATa ade2-1 can1-100 his3-11 trp1-1 ura3-1 leu2-3,112 mft1KAN 7
U678-1C MATa ade2-1 can1-100 his3-11 trp1-1 ura3-1 leu2-3,112 hpr1HIS3 50
WSH-2A MAT ade2-1 can1-100 his3-11 trp1-1 ura3-1 leu2-3,112 hpr1::HIS3 sem1KAN This study
WMT-2C MATa ade2-1 can1-100 his3-11 trp1-1 ura3-1 leu2-3,112 yor045c-101 thp1::KAN This study
BWCH-1B MATa his3 trp1 ura3 leu2 hpr1::HIS3 csn12::KAN This study
BWCS12-3B MATa ade2 his3 trp1 ura3 leu2 csn12::KAN This study
WMM-12D MATa ade2-1 can1-100 his3-11 trp1-1 ura3-1 leu2-3,112 mex67-5 ypr045c-101 This study
WSM-1D MATa ade2-1 can1-100 his3-11 trp1-1 ura3-1 leu2-3,112 ypr045c-101 sem1::KAN This study
WWM-1D MATa ade2-1 can1-100 his3-11 trp1-1 ura3-1 leu2-3,112 ypr045c-101 mft1::KAN This study
WM454-2B MAT ade2-1 can1-100 his3-11 trp1-1 ura3-1 leu2-3,112 ypr045c-101 GAL1p::YLR454w-TRP1 This study
W303-454 MATa ade2-1 can1-100 his3-11 trp1-1 ura3-1 leu2-3,112 GAL1p::YLR454w-TRP1 45
WMC1 MATa ade2-1 can1-100 his3-11 trp1-1 ura3-1 leu2-3,112 mex67-5 35
WFBE046 MATa ade2-1 can1-100 his3-11 trp1-1 ura3-1 leu2-3,112 thp1::KAN 22
BWC9H-1A MATa his3 trp1 ura3 leu2 csn9::KAN hpr1:HIS3 This study
BWC9-4A MAT his3 trp1 ura3 leu2 csn9::KAN This study
BWMN-2B MATa his3 trp1 ura3 leu2 ypr045c::KAN This study
BWMH-8D MAT his3 trp1 ura3 leu2 ypr045cKAN hpr1HIS3 This study
BWMN-1A MATa ade2 his3 trp1 ura3 leu2 This study
BWMN-1A MATa ade2 his3 trp1 ura3 leu2 This study
WA41-2B MATa ade2-1 his3 ura3 leu2-k::ADE2-URA3::leu2-k hpr1::HIS3 ypr045c-101 This study
WA48-1D MAT ade2-1 his3 ura3 leu2-k::ADE2-URA3::leu2-k hpr1::HIS3 med10-101 This study
WB45-5B MATa ade2-1 can1-100 his3 ura3 leu2-k::ADE2-URA3::leu2-k hpr1::HIS3 sch9-101 This study
WA48-4B MAT ade2 his3 trp1 ura3 leu2-k::ADE2-URA3::leu2-k med10-101 This study
WB45-1D MAT ade2 his3 trp1 ura3 leu-2k::ADE2-URA3::leu2-k sch9-101 This study
WA41-1B MATa ade2 his3 trp1 ura3 leu2-k::ADE2-URA3::leu2-k hpr1HIS3 This study
WA41-6B MATa ade2 his3 trp1 ura3 leu2-k::ADE2-URA3::leu2-k This study
WCSHP-3B MATa ade2 his3 trp1 ura3 hpr1::HIS3 csn12::KAN This study
BWMN-2A MAT ade2 his3 trp1 ura3 hpr1::HIS3 This study
BWMN-3B MATa his3 trp1 ura3 hpr1::HIS3 thp3::KAN This study
Thp3-TAP THP3-TAP integrated in BY4741 Open Biosystems
THTCS-9F CSN9-FLAG integrated in the Thp3-TAP strain This study
THTCS-12F CSN12-FLAG integrated in the Thp3-TAP strain This study
SYHPR1 MATa ade2-1 can1-100 his3-11 trp1-1 ura3-1 leu2-3,112 HPR1-FLAG This study
SYTHP3 MATa ade2-1 can1-100 his3-11 trp1-1 ura3-1 leu2-3,112 HPR1-FLAG thp3-101 This study
BTHT-1D MATa ura30 his3 leu20 met-THP3-TAP::HIS3 thp1::KAN This study
BTHH-6C MATa ura3 his3 leu2 met-THP3-TAP::HIS3 hpr1::HIS This study
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In vivo G-less RNA-based run on (GLRO). Strains harboring plasmid pG-Leu-
CYCds or pCYC-LacZ were grown to an OD600 of 0.5 in SC medium lacking
leucine (SC-leu) at 30°C. Run-on assays were carried out as previously described
(60). Run-on products were digested with RNase T1, which cannot degrade
G-less RNA, and resolved by 6% polyacrylamide gel electrophoresis (PAGE).
Dried gels were analyzed with a phosphorimager (Fuji FLA-5100) using Image-
Quant software (Molecular Dynamics). For each sample, the ratio of the total
counts in the 132-nt G-less cassette band to those in the 262-nt G-less cassette
band was determined (Tous et al., unpublished).
TAP-tagged purification of protein complexes. The Thp3-Csn12 complex was
purified by using a TAP-tagged Thp3 protein (from Open Biosystems). The
purification was essentially as described previously (55). The Thp3-TAP protein
was isolated from yeast lysates by affinity purification using an IgG-Sepharose
column. Proteins in the various elution fractions were concentrated with trichlo-
roacetic acid, resolved by 8 to 16% gradient sodium dodecyl sulfate (SDS)-
PAGE, and silver stained for visualization. Only the bands that did not appear in
the negative control for the purification (nontagged strain) were used for matrix-
assisted laser desorption ionization–time of flight (MALDI-TOF) mass spec-
trometry identification.
Coimmunoprecipitation analyses. For the coimmunoprecipitation studies, we
integrated into the strain expressing the Thp3-TAP fusion protein either the
Csn9-FLAG or the Csn12-FLAG fusion construct, which was obtained by PCR
using primers CSN9-FW (5-TCGGAGCTGGGAAACAAAGCTCAAA
CAGAATATATTGGAGtcccaccaccatcatcatcac-3 [lowercase letters indicate the
sequence corresponding to the FLAG epitope]) and CSN9-Rev (5-CTAATAT
CGTCATTATTATGCCTTTTTCATATTTGATTTAactatagggagaccggcaga
tc-3) or CSN12-FW (5-CATCGTTTTCAGTAAGAAGGAGCCCTTTCCCC
ATAGCAAAtcccaccaccatcatcatcac3) and CSN12-Rev (5-TTTTTTTTTCTTC
GTTCAATTATTGACTATTTTTCTATCAactatagggagaccggcagatc), using the
standard procedure.
For ChIP, 50 ml of mid-log-phase YPD culture was incubated, pelleted,
washed, and resuspended in 1 ml of lysis buffer (50 mM Tris-HCl [pH 7.5], 100
mM NaCl, 1.5 mM MgCl2, 0.0075 NP-40, 100 mM dithiothreitol). After break-
age, 5 mg/ml extract was incubated overnight at 4°C with 10 g of anti-FLAG M2
Clone2 monoclonal antibody (Sigma). Thirty microliters of protein A-Sepharose
(10%, wt/vol) was incubated overnight at 4°C in 1 bovine serum albumin–
phosphate-buffered saline (PBS). Afterwards, the protein A-Sepharose was pel-
leted, washed with PBS, incubated with the extract and anti-FLAG antibody for
3 h at 4°C, centrifuged, washed with PBS, and resuspended in 40 l of Laemmli
buffer. Finally, Western immunoblot assays using a 10% acrylamide gel and
either anti-FLAG or anti-TAP rabbit polyclonal antibody (Thermo Scientific)
were performed.
Microarray analysis. Analysis of microarray data was carried out with DNA-
Chip Analyzer (www.dchip.org) (41). Normalization of probe cell files and com-
putation of expression values were performed using the Invariant Set Normal-
ization method and the Model Based method, respectively (41). Genes with
expression increased or decreased by more than 1.5-fold with respect to the wild
type were selected for further study. GO slim terms (Biological Process) were
obtained with the SGD Gene Ontology Slim Mapper (http://www.yeastgenome
.org/cgi-bin/GO/goSlimMapper.pl). The search for statistically significant terms
in the lists of genes up- and downregulated was performed using Gene Ontology
Term Finder (http://www.yeastgenome.org/cgi-bin/GO/goTermFinder.pl). Yeast
open reading frame (ORF) sequences were obtained from http://downloads
.yeastgenome.org/sequence/genomic_sequence/orf_dna/ (May 2009).
Determination of recombination frequencies. Recombination frequencies
were determined as described previously (50), using 12 independent colonies for
each strain studied. Yeast strains were grown on SC medium plates (those
carrying the intrachromosomal direct-repeat system leu2-k::URA3-ADE2::leu2-k)
or on SC medium lacking uracil (SC-ura) (those carrying the plasmid-borne
direct-repeat system LYNS). After 4 days, independent colonies were picked,
resuspended in water, and plated in SC medium containing 5-fluoroorotic acid
for the leu2-k::URA3-ADE2::leu2-k system or on SC-ura-leu plates for the
LYNS system. The number of Ura or Leu recombinant colonies was quan-
tified, and the median frequency of recombination of each strain per viable cell
number was calculated (determined on SC medium or SC-ura).
Miscellaneous. Northern analyses were performed according to standard pro-
cedures with 32P-radiolabeled probes. RNA was isolated from mid-log-phase
cells, transformed with either the tet::lacZ-URA3 or the tet::LEU2 system, and
grown in SC medium without doxycycline. As a 32P-labeled DNA probe, we used
a 3-kb BamHI lacZ fragment, a 0.4-kb ClaI-EcoRV LEU2 fragment, and the
internal 589-bp 28S rRNA fragment obtained by PCR (7). For the MED10 and
SCH9 probes, PCR fragments were obtained from genomic DNA using primers
5ATGGAAACAGCACTAACAATGA3and 5TCAATGGGAGATGTTCTC
TTTA3 (MED10) or 5ATCGTCGAATCAGGATACTGGA3 and 5TTACC
GTTGGCATCGAGTAGAA3 (SCH9).
RNA export was determined by in situ localization with digoxigenin-labeled
oligo(dT)16 (3). Samples were taken from mid-log-phase cultures and shifted to
37° for 4 h. Nuclei (DNA) were visualized by staining with 10 g/ml 4,6-
diamidino-2-phenylindole (DAPI). Analyses were performed in an Olympus
AHBT3 microscope.
RESULTS
A search for suppressors of the gene expression defect of the
hpr1 mutant. To get further insight into mRNP biogenesis
and the functional role of the THO complex in gene expres-
sion, we searched for new genes that could have a function
related to that of THO. For this, we used the centromeric
plasmid pCM184-LAUR containing a 4.15-kb lacZ-URA3
translational fusion under the control of the tet promoter.
Wild-type cells express this fusion protein, and consequently,
they can form colonies on SC-ura. On the contrary, THO
mutants, like the hpr1 mutant, do not express the lacZ-URA3
fusion at sufficient levels and therefore do not form colonies on
SC-ura (35). Using this assay, we searched for new hpr1
suppressors with the yeast genomic library mutagenized with
the mTn3-lacZ/LEU2 transposon (5). From approximately
22,000 yeast transformants with the insertion library tested, we
selected 90 clones that recovered the capacity of hpr1 mutant
cells to grow in SC-ura. After confirming by Northern blotting
that pLAUR RNA levels were indeed increased (data not
shown) and that the Tn3 insertion marker (LEU2) cosegre-
gated with the suppressor phenotype, genomic DNA from the
selected clones was isolated and the DNA around the insertion
was sequenced. This allowed us to select three different mu-
tants. In two of them, Tn3 was inserted in the promoter of the
SCH9 and MED10 essential genes (sch9-101 and med10-101),
respectively. Tn3 insertion caused a reduction in the expression
of both genes (Fig. 1C). The third insertion was in the middle
of the ORF of YPR045c, a new gene that will be referred to as
THP3 (THO-related protein 3) from now on (thp3-101). Fig-
ure 1A shows that hpr1 thp3-101, hpr1 med10-101, and
hpr1 sch9-101 double mutants harboring the pLAUR system
recover the capacity to grow in SC-ura. In Fig. 1B, we show
that, indeed, there is an increase in mRNA levels of the lacZ-
URA3 fusion in the double mutants compared with that in the
hpr1 simple mutant.
Partial suppression of all hpr1 phenotypes by mutation of
YPR045c/THP3, MED10, and SCH9. We assayed next whether
suppression of the gene expression defect of hpr1 mutant
cells by thp3-101, med10-101, and sch9-101 was general for any
phenotype of hpr1 mutant cells, including mRNA export and
recombination or whether it was specific for transcription.
RNA export of total poly(A) RNA was assayed by in situ
hybridization with Cy3-conjugated oligo(dT)s. As shown in
Fig. 2A, the strong nuclear accumulation of poly(A) RNA
disappeared from all double mutants. Finally, we determined
the ability of the three mutations to suppress the hyperrecom-
bination phenotype of the hpr1 single mutant. As shown in
Fig. 2B, the three mutations were able to reduce the frequency
of recombination by 4- to 5-fold. Suppression was not complete
for any of the three phenotypes analyzed, but it was clearly
general and not specific for a particular phenotype. This sug-
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gests that the three mutations suppressed the general effect of
THO mutations.
Sch9 is a major target of TORC1 in S. cerevisiae (62). It is a
kinase involved in regulation of RNAPIII transcription by
phosphorylation of the Maf1 repressor (39). Nut2/Med10 is a
component of the RNAPII mediator complex (27). The puta-
tive function of the SCH9 and MED10 genes related to tran-
scription might cause the mutations to reduce the rate of tran-
scription, alleviating the need for the THO complex in mRNP
biogenesis (see Discussion). Little is known about Thp3/
Ypr045c. It is a nuclear protein with a conserved SAC3 do-
main, which is also found in the Sac3 component of the THSC
complex, but its function is unknown. In high-throughput stud-
ies, it has been shown to interact physically with Yra1 and
genetically with the Taf9 component of SAGA (37, 47). A
recent global analysis of genetic and physical interaction data
has shown that Thp3/Ypr045c is also related to Sem1, a factor
that interacts with the proteasome and with THSC/TREX-2
(66), but the physiological meaning of this interaction is un-
known. For these reasons, we focused all our work on Thp3/
Ypr045c.
THP3 mutation specifically suppresses THO complex mu-
tations. We wondered whether the suppression conferred by
thp3-101 was specific for THO mutations or if it was general for
mutations in other genes with a role at the transcription-RNA
export interface that conferred phenotypes similar to those
conferred by THO mutations. We tested the ability of thp3-101
to suppress mft1, a subunit of THO, the thp1 mutation of
the THSC complex, and the mex67-5 mutation of the Mex67-
Mtr2 RNA export factor. As shown in Fig. 3, thp3-101 was able
to suppress the inability of the mft1 mutant to form colonies
in medium lacking uracil and therefore to express lacZ-URA3
at the appropriate levels to support growth. Instead, this sup-
pression was not observed in thp1 thp3-101 and mex67-5
FIG. 1. Suppression of the gene expression phenotype of hpr1 by
the YPR045c/THP3, MED10, and SCH9 mutations. (A) Phenotypic
analysis of hpr1 (U678-1C), hpr1 thp3-101, hpr1 med10-101, and
hpr1 sch9-101 isogenic strains transformed with the pLAUR system.
The capacity of each strain to form colonies on SC-ura after 4 days at
30°C is shown. A scheme of the pLAUR system is shown at the top.
(B) Northern blot analyses of the strains shown in panel A. RNA levels
in arbitrary units (A.U.) were obtained in a Fuji FLA 3000 and nor-
malized with respect to the rRNA levels of each sample. (C) Northern
analyses of the MED10 and SCH9 endogenous genes in the wild-type
(WT; WA41-6B) and med10-101 (WA48-4B) and sch9-101 (WB45-1D)
mutant congenic strains. Other details are as in panel B.
FIG. 2. Suppression of the RNA export and hyperrecombination
phenotypes of hpr1 mutant cells by the YPR045c/THP3, MED10, and
SCH9 mutations. (A) Subcellular localization of poly(A) RNAs de-
tected by in situ hybridization with digoxigenin-labeled oligo(dT)16 of
hpr1 (U678-1C), hpr1 thp3-101, hpr1 med10-101, and hpr1 sch9-
101 isogenic strains. Samples were taken from mid-log-phase cultures
and shifted to 37°C for 4 h. (B) Recombination frequency of the
intrachromosomal direct-repeat system leu2-k::URA3-ADE2::leu2-k in
hpr1 (AYW3-3C), hpr1 ypr045c-101 (WA41-2B), hpr1 med10-
101(WA48-1D), and hpr1 sch9-101 (WB45-5B) mutant isogenic
strains. A schematic of the recombination assay is shown at the top.
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thp3-101 double mutants. Actually, the mex67-5 thp3-101
double mutant is very sick and does not grow at 30°C (Fig.
3). This implies that thp3-101 specifically suppresses muta-
tions of the THO complex, not only of Hpr1, whereas it does
not suppress other mRNP biogenesis- and export-related
mutations. Therefore, Thp3 might be a protein with a func-
tion related to that of THO.
Transcription is impaired in thp3 mutants. Given the ge-
netic relationship of the thp3 mutation with THO mutations,
we asked whether this mutation also impairs transcription
elongation. We first determined the capability of thp3-101 mu-
tant cells to transcribe tetp::lacZ-URA3 of the plasmid-borne
pLAUR system. As shown in Fig. 4A, thp3-101 mutants accu-
mulated lacZ-URA3 RNA at levels below 50% of that of the
wild type. However, in the shorter tetp::LEU2 control system,
the LEU2 transcript accumulated at 30% of the wild-type lev-
els (Fig. 4B). This suggests that the thp3 mutant may have a
defect in the activation of the tet promoter.
Consequently, we would expect that thp3-101 may have a
general effect in transcription.
Previously, analysis of RNAPII recruitment by ChIP analysis
was used to assess in vivo transcription impairment in several
mutants. ChIPs were performed at the 8-kb-long YLR454c
gene fused to the GAL1 promoter in three different regions (5
end, middle, and 3 end). In the wild-type strain, above 95% of
the RNAPIIs reached the 3 end of the gene and this value was
significantly reduced in mutants defective in transcription elon-
gation, such as spt4 or THO mutants (43). Analysis of the
distribution of RNAPII at the GAL1p::YLR454 construct re-
vealed that the relative levels of RNAPII throughout the pro-
moter, 5, and 3 regions did not change in wild-type or thp3-
101 mutant cells, but in thp3-101 mutant cells, the overall levels
were half of the wild-type levels at the three positions tested
(Fig. 4C). These results indicate a general reduction in tran-
scription but do not offer a clear answer about an effect on
transcription elongation. In this sense, it is worth noting that
FIG. 4. Transcription analysis of thp3 mutants. (A) Northern
analysis of the Ptet::lacZ-URA3 fusion in the wild-type (wt or WT)
and thp3 mutant (BWMN-2B) congenic strains. Other details are
as in Fig. 1B. A.U., arbitrary units. (B) Gene expression analysis of
the pCM189-LEU2 construct. Analysis of the capacity of the thp3
mutant and wild-type strains to transcribe the Ptet::LEU2 construct,
measured by Northern blot analysis, is shown. Other details are as
in Fig. 1B. (C) RNAPII occupancy at the GAL1-YLR454w gene in
the thp3-101 mutant. ChIP analyses (using 8WG16 anti-RNPII an-
tibodies) in the wild-type (W303) and thp3-101 mutant (WM454-
2B) isogenic strains carrying the GAL1p::YLR454w fusion construct
located at the endogenous YLR454w chromosomal locus are shown.
A schematic of the gene and the PCR-amplified fragments is shown.
The DNA ratios in the promoter (bars 1), 5 (bars 2), and 3 (bars
3) regions were calculated from the DNA amounts in these regions
relative to that in the intergenic region. Medians and SD of three
independent experiments are shown. (D) Sensitivity of the thp3
mutant to 6-azauracil. Tenfold serial dilutions of the wild-type
(BY4741) and thp3 and spt4 mutant isogenic strains were cul-
tured for 4 days at 30°C in YPD medium either with or without
6-azauracil.
FIG. 3. Specificity of the suppression of the gene expression phe-
notype of the hpr1mutant by the THP3 mutation. Phenotypic analysis
of mft1 (WMK-1A), mft1 thp3-101 (WWM-1D), mex67-5 (WMC1),
mex67-5 thp3-101 (WMM-12D), thp1 (WFBE046), and thp1 thp3-
101 (WMT-2C) mutant strains transformed with the pLAUR system.
The capacity of each strain to form colonies on SC-ura after 4 days at
30°C or 26°C is shown. Other details are the same as in Fig. 1A.
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mutations in the yeast PAF complex show a similar RNAPII
ChIP distribution (45). However, this complex has been shown
to be required for transcription elongation in vitro (57) and in
vivo (C. Tous et al., unpublished). Similarly, the role of human
PAF in transcription elongation has been demonstrated in a
chromatin template (36).
Furthermore, we have observed that, as is the case for the
thp3-101 allele obtained in our screening, the thp3 null mu-
tant is able to suppress the transcriptional defect of the hpr1
mutant (see Fig. S1 in the supplemental material) and is sen-
sitive to 6-azauracil, an inhibitor of transcription elongation
(Fig. 4D).
Finally, we directly assayed the effect of thp3 on transcrip-
tion elongation. This was done in vivo with a novel assay based
on a run-on analysis of transcription units carrying two G-less
cassettes (GLRO assays). The GLRO assays are based on two
plasmid-borne constructs containing two G-less cassettes of
262 nucleotides (nt) and 132 nt separated by a 243-nt CYC1
(GLRO-short) or a 2-kb lacZ (GLRO-long) fragment as a
spacer sequence; both cassettes are under the control of the
strong and constitutive TDH3 promoter (Tous et al., unpub-
lished) (Fig. 5A). Transcription elongation was measured by
run-on analysis, followed by purification of synthesized RNAs
and subsequent RNase T1 treatment, which does not degrade
G-less RNAs. Figure 5B shows that the efficiency of transcrip-
tion elongation, as assayed by the ability to transcribe the
downstream 243-nt G-less cassette versus the upstream 132-nt
cassette, was 80% of the wild-type level for the GLRO-short
system and 56% of the wild-type level for the GLRO-long
system. This result clearly shows that transcription elongation
is defective in thp3 mutant cells, this defect being more evi-
dent for long transcripts, consistent with the idea that the
longer the transcription unit analyzed the higher the transcrip-
tion elongation defect expected, even though it does not ex-
clude the possibility that it can also work in initiation.
Thp3 is recruited to ORFs in a transcription-dependent
manner. We next asked whether this protein is recruited to
transcriptionally active ORFs. For this, we used a wild-type
strain containing a TAP-tagged Thp3 protein and determined
by quantitative PCR the recruitment of Thp3 to the constitu-
tive PMA1 gene and the regulated GAL1 gene, the latter under
both repressed (2% glucose) and activated (2% galactose)
conditions. As shown in Fig. 6A, Thp3 was clearly recruited to
the three regions of PMA1, the proximal 5-end, the middle,
and the distal 3-end regions, with similar amounts in all of the
regions. For GAL1 under repressed conditions, Thp3 recruit-
ment was almost undetectable along the 5-end, middle, and
3-end ORF regions, as well as the untranslated region. In-
stead, under activated transcription conditions, Thp3 was re-
cruited all over the gene from the 5-end to the 3-end ORF
region (Fig. 6B). Therefore, consistent with its putative role in
elongation, Thp3 is recruited to transcribed ORFs.
Thp3 forms a physical and functional complex with Csn12.
To get further insight into the function of Thp3, we undertook
a biochemical analysis aimed at identifying other proteins that
physically interacted with Thp3 in vivo. For this, we used a
strain carrying a TAP-tagged Thp3 protein to purify in vivo
Thp3-bound proteins by two-step chromatography purifica-
tion. After establishing that the protein bands obtained in the
purification were specific to the Thp3-TAP strain (Fig. 7A), we
identified them by MALDI-TOF. As shown in Fig. 7B, Csn12,
which has been shown to interact with the CSN, was clearly
copurified with Thp3. In addition to Csn12, we obtained sev-
eral ribosomal proteins that appeared in the Thp3-TAP but
not in the control strain (Fig. 7A and B).
We asked next whether Thp3-Csn12 forms a functional unit
and whether or not it functions in the context of the signalo-
some. For this, we analyzed whether csn12 suppresses the
transcription defect of hpr1 mutant cells, as was the case for
thp3, and we compared the results with those of csn9, a bona
fide representative of the signalosome complex and the related
sem1 mutant. Indeed, csn12, but not csn9 or sem1, was
able to suppress the thermosensitivity of hpr1, as well as its
inability to transcribe the lacZ-URA3 ORF, as determined by
the capacity to grow on SC-ura (Fig. 8A). We have also
checked that the csn12 mutation, as is the case for thp3,
partially suppresses the hyperrecombination phenotype due to
hpr1, as determined with the LYNS plasmid-borne recom-
bination system (Fig. 8B). Therefore, suppression of THO
FIG. 5. Effect of thp3 on transcription elongation. (A) Schematic
of tandem G-less cassette constructs pG-leu-CYCds (GLRO-short)
and pCYCLacZ (GLRO-long). (B) GLRO analysis of wild-type (wt;
BY4741) and thp3 mutant isogenic strains transformed with pG-leu-
CYCds and pCYCLacZ systems. The rectangles represent the two
G-less cassettes. Transformants were grown in SC-leu medium to ex-
ponential phase and run on transcription assays were performed as
described in Materials and Methods. Radioactivity incorporated into
the G-less cassettes was quantified in a Fuji FLA-5100. For each
sample, the ratio of the total numbers of counts incorporated into the
distal versus the proximal G-less cassette was determined and normal-
ized against the ratio for the same construct in the wild-type strain. The
average and SD of three independent experiments are shown. The
values to the left are molecular sizes in nucleotides.
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mutations is specifically shared by thp3 and csn12 and not by
mutations in the signalosome complex. In agreement with this
conclusion, we have observed that thp3 and csn12 confer
sensitivity to mycophenolic acid (MPA), a drug that depletes
cells of GTP, impairing transcription elongation (28), whereas
this is not the case for csn9 (Fig. 8C). We have further
confirmed by coimmunoprecipitation analyses that the inter-
action between Thp3 and Csn12 is specific and not shared by
other components of the signalosome. As shown in Fig. 9,
Thp3 coprecipitated with Csn12 but not with Csn9. Moreover,
Northern analysis of transcription of csn12 mutant cells re-
vealed that they yield about 75% of the total lacZ-URA3 tran-
scripts from the pLAUR system, implying a defect in transcrip-
tion, although weaker than that of thp3 mutant cells in this
assay (Fig. 10A). However, in the shorter tetp::LEU2 control
system, the LEU2 transcript accumulated at the same levels as
in the wild type (Fig. 10B), implying that thp3 did not have a
negative effect on the activation of the tet promoter. Finally, to
further confirm that Csn12 was not only physically but func-
tionally related to Thp3, we determined the ability of a TAP-
tagged Csn12 protein to immunoprecipitate chromatin. As
shown in Fig. 10C, Csn12 was recruited throughout the PMA1
gene at the three positions tested, the 5 end, the middle, and
the 3 end. Furthermore, using the inducible GAL1 endoge-
nous gene, we have seen that, as is the case for Thp3, Csn12 is
recruited to transcribed chromatin. Recruitment to GAL1 was
detected only in galactose-containing medium (Fig. 10D). We
can therefore conclude that Csn12 and Thp3 form a physical
and functional unit with a role in transcription. Our results
therefore confirm a role for Thp3-Csn12 in transcription elon-
gation in vivo that is functionally independent of the signalo-
some.
To know whether the presence of a number of ribosome
proteins in the Thp3-TAP has an additional biological meaning
requires a more elaborate analysis. Nevertheless, the fact that
ribosomal proteins were not observed in our blank control
opens the possibility that Thp3-Csn12 physically interacts with
a ribosomal counterpart. Determination of whether or not this
implies an additional posttranscriptional function for Thp3-
FIG. 6. Recruitment of Thp3-TAP to transcribed chromatin.
(A) ChIP analysis of Thp3 at the endogenous PMA1 gene in the
wild-type strain carrying TAP-tagged Thp3 (from Open Biosystems). A
schematic of the gene analyzed and the amplified PCR fragments is
shown. The median and SD of three independent experiments are
shown. (B) ChIP analysis of Thp3 at the endogenous GAL1 gene.
Other details are as in panel A.
FIG. 7. Purification of a Thp3 protein complex. (A) TAP and its
blank control. Isogenic (BY4741) Thp3-TAP and untagged strains
were used for TAP. A 4 to 12% gradient gel (NuPAGE Novex Bis-Tris
from Invitrogen) and silver stain were used. (B) Thp3-TAP proteome.
Silver-stained 8 to 16% gradient SDS-PAGE of the Thp3-TAP-tagged
complex purified from wild-type cells. In addition to the full Thp3 and
Csn12 proteins, we obtained truncated Thp3 (Thp3-t); ribosomal pro-
teins Rpl3 (band 1), Rpl4 (bands 2 and 4), Rpl7 (band 6), Rps13 (band
8), and Rps16 (band 9); and the common TAP contaminants Tdh3
(band 3), Eef2 (calmodulin-dependent protein) (band 5), and human
calpain (band 7).
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Csn12, such as translation or ribosome biosynthesis, requires
further investigation.
Genome-wide analysis of gene expression in thp3 mutants.
To assay if the effect of thp3 was due to the downregulation
of a transcription elongation factor, we determined the tran-
script levels of the whole genome in thp3 mutant cells by
microarray gene expression analysis. Using the Affymetrix plat-
form, we determined the RNA levels of 5,800 genes. Among
these, 76 were significantly downregulated (levels 0.5 times
that of the wild type) (see Table S1 in the supplemental ma-
terial). They do not share any structural or functional features,
and none of them has been shown to have a role in transcrip-
tion elongation. Therefore, the effect of thp3 on transcription
does not seem to be mediated by a second gene.
Interestingly, a comparative analysis with previous data for
the thp1 and tho2 mutants (44) revealed that 28 genes
downregulated in the thp3 mutant are downregulated in the
tho2 mutant and that 30 genes downregulated in the thp3
mutant are downregulated in the tho2 mutant. Moreover, 26
of these genes are the same in the three mutants. Interestingly,
most of these 26 genes are either subcentromeric (14 out of 26)
or subtelomeric (10 out of 26) (see Table S2 and Fig. S2 in the
supplemental material). This suggests an intriguing link be-
tween Thp3-Csn12 and heterochromatin-proximal regions that
would require further analysis to evaluate its biological signif-
icance.
DISCUSSION
A search for suppressors of the gene expression defect of the
hpr1 mutant has led to the isolation of insertion mutations in
YPR045c, MED10, and SCH9. Previous screenings for suppres-
sors of the hpr1 mutation have identified several factors in-
volved in transcription. Thus, mutations in components of the
mediator of RNAPII like Hrs1/Med3, Srb2/Med20, Gal11/
Med15, and Sin4/Med16 have been shown to suppress hpr1
hyperrecombination (14, 51, 52, 58). Besides, mutations in the
Rad3 component of the TFIIH initiation factor suppress the
accumulation of transcripts at the site of transcription in mft1
mutants (33), and the soh alleles of Med31, Rpb2, and TFIIB
suppress the hpr1 mutant thermosensitivity phenotype (14).
Our identification of Med10 as a suppressor of hpr1 consti-
tutes new evidence that a defective mediator or RNAPII pro-
tein suppresses THO mutations. Interestingly, Soh1/Med31
has been shown to interact with Nut2/Med10 by two-hybrid
assay and affinity capture (10). This could imply that a subset of
FIG. 8. Genetic analysis of the Thp3 protein complex. (A) Growth
on SC-ura of hpr1 thp3 (BWMH-8D), hpr1 csn12 (BWCH-1B),
hpr1 sem1 (WSH-2A), and hpr1 csn9 (BWC9H-4A) mutant con-
genic strains carrying the pLAUR system and growth of the same
strains in YPD at 30 and 37°C. Other details are as in Fig. 1A. (B) Sup-
pression of the hyperrecombination phenotype of the hpr1 mutant by
the thp3 and csn12 mutations. The recombination frequencies of the
plasmid-borne direct-repeat system LYNS in the hpr1 (BWMN-
2A), hpr1 thp3 (BWMN-3B), and hpr1 csn12 (WCSHP-3B) mu-
tant congenic strains are shown. A schematic of the recombination
assay is shown at the top. (C) Serial dilutions of the wild-type (WT;
BY4741) and thp3, csn12, and csn9 mutant isogenic strains cul-
tured in YPD medium with and without MPA (150 g/ml) at 37°C.
FIG. 9. Specificity of the interaction between Thp3 and Csn12.
Experiments in which Thp3-TAP was coimmunoprecipitated with
Csn12-FLAG (left) or Csn9-FLAG (right) are shown. Isogenic strains
with no tag (BY4741) or carrying both the Thp3-TAP fusion protein
and either the Csn12-FLAG (THT-12FLAG) or the Csn9-FLAG
(THT-9FLAG) fusion protein were used. IP, immunoprecipitate; WB,
Western blotting.
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mediator or RNAPII proteins may functionally interact with
THO. However, it seems likely that the common behavior of
these suppressors, including med10, is a reduction in transcrip-
tion firing or transcription efficiency, consistent with the ob-
servation that a decrease in the strength of transcription can
alleviate hpr1 gene expression defects (33, 34).
The second suppressor isolated in this study is Sch9, a major
target of TORC1 in S. cerevisiae (62). It is a kinase involved in
the regulation of RNAPIII-mediated transcription (39). Inter-
estingly, SCH9 mutations have also been shown to suppress
other transcription-associated recombination events in yeast,
as is the case for HOT1-stimulated recombination and ribo-
somal DNA recombination (53). SCH9 mutations also sup-
press the genomic instability of null mutants of the Sgs1 DNA
helicase involved in double-strand break repair (43). These
results suggest that Sch9 could play a novel role in the control
of genomic integrity, but the molecular basis and biological
significance of this putative role remain to be seen. Interest-
ingly, different types of genetic interactions have been reported
for SCH9 with SEM1 and SOH1/MED31 (18) and with MED10
(59). Sem1 physically interacts with the THSC complex, and its
mutation shows defects similar to those observed in THO and
THSC complex mutants (15, 66). Altogether, these data may
indicate that Sch9, Nut2/Med10, and Soh1/Med31 act in the
same genetic pathway, the absence of which alleviates the
phenotypes of THO mutants, presumably by altering transcrip-
tion and mRNP biogenesis to levels that tolerate the absence
of THO, as has been suggested for other suppressors (33, 34).
Notably, our suppressor analysis has identified Ypr045c
(Thp3). Little is known about this protein. It is nuclear, and it
has been previously shown to coimmunoprecipitate with Csn12
together with other proteins, including the Yra1 mRNA export
factor (37). We show here that Thp3 has a role in transcription.
However, the defect of the thp3 mutant is not similar to that of
THO mutants. This is not surprising, given that mutations in
the mediator and other transcription factors that also suppress
hpr1 mutations do not have the same function or effect as THO
(14, 51, 58). thp3 mutants have a defect in transcription at both
the initiation and elongation steps. The recruitment of Thp3
throughout the whole ORF under active transcription condi-
tions suggests an active role for Thp3 during transcription
elongation, although it does not eliminate the possibility of a
role in other transcription steps. This active role is confirmed
by the sensitivity to 6-azauracil and with the transcription elon-
FIG. 10. Characterization of Csn12. (A) Northern analysis of the lacZ-URA3 fusion in wild-type (wt; BWMN-1A) and csn12 mutant
(BWCS12-3B) congenic strains. Other details are as in Fig. 1B. A.U., arbitrary units. (B) Northern analysis of the tetp::LEU2 fusion. Other details
are as in panel A. (C) ChIP analysis of TAP-tagged Csn12 at the PMA1 gene. (D) ChIP of Csn12-TAP at the GAL1 gene. Other details are as
in Fig. 6.
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gation defect that the thp3 mutant shows in the novel GLRO
in vivo assay reported here. Besides, we show by genome-wide
microarray gene expression analysis that 76 genes show a sig-
nificant reduction in the steady-state levels of RNA accumu-
lation in the thp3 mutant. This reduction may be due not only
to a decrease in elongation efficiency but likely also to a neg-
ative effect on the activation of some promoters, although it
cannot be established whether or not this effect is due to a
direct role of Thp3-Csn12. Twenty-six of the genes that are
downregulated in the thp3 mutant are also downregulated in
THO and THSC mutants, and 24 of these are located in either
subtelomeric or subcentromeric regions. Interestingly, it has
recently been shown that src1, which interacts genetically
with THO mutations, is also defective in the expression of
subtelomeric genes (26). This opens the possibility that the
chromatin structure or nuclear localization of subtelomeric
genes makes the expression of such genes particularly depen-
dent on transcription factors such as Thp3-Csn12, THO, and
THSC.
Although it has been shown that Ypr045c/Thp3 interacts
physically with many factors, including Yra1 and Sem1 (15, 37),
purification of a protein complex containing only Ypr045c/
Thp3 and Csn12 has not been reported. Csn12 was previously
described as part of the CSN. Csn12, like Thp3, coimmuno-
precipitates with Sem1, which also interacts with the protea-
some and the THSC/TREX-2 complex (15, 66). We did not
obtain either Sem1 or any component of the previously men-
tioned complexes, implying that Thp3 and Csn12 may form an
independent core complex in vivo. Despite the relationship
between Csn12 and the signalosome (46), we did not see a
physical interaction with any CSN component in our TAP.
Moreover, Thp3 coimmunoprecipitated with Csn12 and not
with CSN component Csn9. This, together with the fact that
csn12 suppresses different phenotypes of hpr1 mutant cells
and shows a defect in gene expression while this is not the case
for csn9, suggests that Thp3 and Csn12 form an independent
functional unit with a role in transcription. Besides, as is the
case for Thp3, recruitment of Csn12 throughout the whole
ORF under active transcription conditions is consistent with a
role in transcription.
It is interesting that, in addition to Csn12, we also obtained
the ribosomal proteins Rpl3, Rpl4, Rpl7, Rps13, and Rps16 by
Thp3-TAP. Actually, there are more data that might indicate
some sort of relationship between the Thp3-Csn12 complex
and ribosome biogenesis. Thus, it has been shown that Thp3
interacts physically with Ebp2, Rpf2, and Rrs1 (37), the three
of them being implicated in preribosomal 60S particle assem-
bly. Besides, genetic interactions between thp3 and rps16 mu-
tants and between csn12 and rpl37 and rpso mutants have also
been shown (11). Altogether, these data indicate that the phys-
ical interaction between the Thp3-Csn12 complex and the ri-
bosomal proteins may imply a functional interconnection be-
tween Thp3-Csn12 and ribosome biogenesis or translation that
requires further analysis. In this sense, it is worth noting that it
has recently been shown that the yeast RNAPII holoenzyme
subunits Rpb4 and Rpb7 shuttle between the nucleus and the
cytoplasm, functioning in both transcription and translation
(29). Besides, it is interesting that several ribosomal proteins,
including L7, S13, and S16, found in our TAPs can be modified
by NEDD8 (67), which opens the possibility of an interaction
between Thp3-Csn12 and the CSN. In this sense, a more de-
tailed study is required to determine to what degree Thp3-
Csn12 might also be involved in ribosomal biogenesis and
metabolism, apart from or in relation to its role in transcription
elongation shown here.
Recently, it has been suggested that CSN12 and YPR045c/
THP3 may be involved in splicing, based on the profile of
genetic interactions of csn12 and on the splicing-specific mi-
croarray gene expression patterns of mutants affected in both
genes (66). Our work further supports a role for these proteins
in RNA metabolism. Nevertheless, as all of our observations
are based on intronless genes, we conclude that the role of
Thp3 in transcription elongation that we describe here is in-
dependent of splicing.
Different studies have provided indications for a putative
relationship between the CSN and gene expression. Thus, it
was originally described as a transcriptional repressor of a
range of Arabidopsis genes (13, 16, 64), and mutations of dif-
ferent subunits of the CSN in Drosophila leads to misregulation
of 20% of the transcriptome during larval development (49).
The molecular basis of this relationship, whether direct or
indirect, is unclear (for a review, see reference 6).
Interestingly, the Thp3-Csn12 complex has in common with
THSC and the 26S proteasome the presence of one subunit
with a Sac3 domain and another subunit with a PAM domain
(8, 15, 66). In addition to the known connection of THSC with
transcription elongation and mRNP biogenesis (24), different
studies have also related the proteasome to transcription.
Thus, the 19S regulatory particle of the proteasome has been
shown to have a role in transcription elongation (17), and its
components are recruited to the entire ORF of transcribed
genes (23). As with THSC (56) and Thp3 (47), a genetic in-
teraction between SAGA and the proteasome has been re-
ported (38). Altogether, these results support a role for Thp3-
Csn12 in transcription elongation at the interface with mRNA
processing.
Using ChIP, we have ruled out the possibility that the chro-
matin recruitment of THO is dependent on Thp3 and vice
versa (Fig.S3). However, the role of Thp3 in transcription may
provide a simple explanation for the suppression of the tran-
scriptional phenotype of THO mutants. As discussed above for
other hpr1 suppressors, suppression could be due to a reduc-
tion in the transcription rate. However, there are several rea-
sons to believe that this might not be the case. Previously
identified mutations that suppress hpr1 on the basis of reduc-
ing transcription also suppresses the thp1 mutation of the
THSC complex (22), whereas thp3 only suppresses THO mu-
tations. Also, the physical interaction of Thp3 with the Yra1
and Sem1 proteins involved in RNA export (15, 19), the ge-
netic interaction that we observed between thp3-101 and
mex67-5 (Fig. 3), and the observation that the group of genes
downregulated in thp3, thp1, and tho2 mutant cells is en-
riched in subtelomeric genes, similar to RNA processing pro-
tein Src1 mutants, suggest a functional interaction of Thp3-
Csn12 with mRNP biogenesis and export that is not observed
for general transcription factors. Further analysis is required to
understand the mechanism of the suppression of THO mutants
by Thp3-Csn12 mutations and to establish the precise role of
Thp3-Csn12 in transcription at both the initiation and elonga-
tions steps, its connection to mRNP biogenesis, and whether or
VOL. 31, 2011 Thp3-Csn12 AND TRANSCRIPTION ELONGATION 683
 o
n
 O
ctober 5, 2015 by USE/BCTA.G
EN UNIVERSITARIA
http://m
cb.asm
.org/
D
ow
nloaded from
 
not this role is related to the CSN. Our study, however, opens
new perspectives on our understanding of the connection of
transcription with mRNP biogenesis and export.
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